<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39440172</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Case-control study on risk factors for in-hospital mortality in patients with severe COVID-19.</ArticleTitle><Pagination><StartPage>1424720</StartPage><MedlinePgn>1424720</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1424720</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1424720</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The purpose of this study was to identify independent risk factors affecting patient survival and explore predictors of severe cases of coronavirus disease 2019 (COVID-19).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a retrospective, observational, case-control study on adult patients with severe COVID-19 who were admitted to affiliated hospitals in Tianjin between December 18, 2022, and January 31, 2023. We used univariate and multifactorial logistic regression analyses to analyze demographic indicators, comorbidity profiles, and laboratory parameters in two groups of patients (deceased and surviving) to identify independent risk factors for death in patients with severe COVID-19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Patients in the deceased group were older than those in the survival group (<i>p</i> = 0.018), and there were more cases of coexisting respiratory insufficiency in the deceased group (<i>p</i> = 0.002). Additionally, laboratory test results for white blood cell count (WBC) and creatine kinase (CK) showed significantly higher values in the deceased group (<i>p</i> = 0.047 and <i>p</i> = 0.029, respectively), while arterial oxygen partial pressure (PAO2) showed significantly lower values compared to the survival group (<i>p</i> = 0.021). Age, respiratory insufficiency, WBC<sub>H</sub> (highest WBC value), CK<sub>H</sub> (highest CK value), and PAO2<sub>F</sub> (first PAO2 value) had area under curve (AUC) values of 0.698, 0.838, 0.721, 0.744, and 0.633, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The main risk factors for mortality in patients with severe COVID-19 that we identified in this study were the advanced age of patients, coexisting respiratory insufficiency, elevated levels of WBC and CK, and decreased levels of PAO2. Elevated WBC and CK laboratory parameters, in particular, demonstrated good predictive value for in-hospital mortality risk.</AbstractText><CopyrightInformation>Copyright © 2024 Wu, Yin, Han, Cai, Guo, Jin, Wu and Cheng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Kemei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yin</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Han</LastName><ForeName>Jiangqin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Qiuhan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jinling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yupei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">case–control study</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">retrospective studies</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">risk prediction models</Keyword><Keyword MajorTopicYN="N">severe COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39440172</ArticleId><ArticleId IdType="pmc">PMC11493594</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1424720</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270–3. doi: 10.1038/s41586-020-2012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. . C4591001 clinical trial group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. (2020) 383:2603–15. doi: 10.1056/NEJMoa2034577, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. (2020) 92:401–2. doi: 10.1002/jmv.25678, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao CL, Wei WL, Zhang JQ, Bi QR, Li JY, Khan I, et al. . Traditional Chinese medicines against COVID-19: a global overview. World J Tradit Chin Med. (2022) 8:279–313. doi: 10.4103/2311-8571.353502</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2311-8571.353502</ArticleId></ArticleIdList></Reference><Reference><Citation>Upreti S, Prusty JS, Kumar A, Samant M. Identification of SARS-CoV-2 spike protein inhibitors from Urtica dioica to develop herbal-based therapeutics against COVID-19. World J Tradit Chin Med. (2023) 9:61–70. doi: 10.4103/2311-8571.358784</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2311-8571.358784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z, Liu YY, Chen YM, Dong JC. Traditional Chinese medicine pattern classification and herbal medicine for COVID-19. World J Tradit Chin Med. (2023) 9:81–93. doi: 10.4103/2311-8571.351792</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2311-8571.351792</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. (2020) 323:1239–42. doi: 10.1001/jama.2020.2648, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683–90. doi: 10.1001/jamaneurol.2020.1127, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. (2020) 5:428–30. doi: 10.1016/S2468-1253(20)30057-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30057-1</ArticleId><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Infectious Diseases . COVID-19, a pandemic or not? Lancet Infect Dis. (2020) 20:383. doi: 10.1016/S1473-3099(20)30180-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30180-8</ArticleId><ArticleId IdType="pmc">PMC7118638</ArticleId><ArticleId IdType="pubmed">32178762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. . Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. (2020) 14:535–45. doi: 10.1016/j.dsx.2020.04.044, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.044</ArticleId><ArticleId IdType="pmc">PMC7200339</ArticleId><ArticleId IdType="pubmed">32408118</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:811–8. doi: 10.1001/jamacardio.2020.1017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis G, Belveyre T, Goetz C, Gibot S, Dunand P, Conrad M, et al. . Comparison of SARS-CoV-2 variants of concern alpha (B.1.1.7) vs. Beta (B.1.351) in critically ill patients: a multicenter cohort study. Front Med (Lausanne). (2022) 9:828402. doi: 10.3389/fmed.2022.828402</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.828402</ArticleId><ArticleId IdType="pmc">PMC8960192</ArticleId><ArticleId IdType="pubmed">35360736</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheward DJ, Kim C, Ehling RA, Pankow A, Castro Dopico X, Dyrdak R, et al. . Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study. Lancet Infect Dis. (2022) 22:813–20. doi: 10.1016/S1473-3099(22)00129-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00129-3</ArticleId><ArticleId IdType="pmc">PMC8930016</ArticleId><ArticleId IdType="pubmed">35305699</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, Zhuo Y, Du X, Qin FX, Huang Y. Antigenicity and infectivity of severe acute respiratory syndrome coronavirus 2 omicron subvariants EG.5.1, XBB.2.3, FL.1.5.1, and BA.2.86. MedComm. (2020) 5:e589. doi: 10.1002/mco2.589, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.589</ArticleId><ArticleId IdType="pmc">PMC11161722</ArticleId><ArticleId IdType="pubmed">38855459</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People’s Republic of China . Guideline on diagnosis and treatment of novel coronavirus pneumonia (interim 10th edition). Infect Dis Info. (2023) 36:18–25. doi: 10.3969/j.issn.1007-8134.2023.01.02</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1007-8134.2023.01.02</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. Lancet. (2022) 400:1213–22. doi: 10.1016/S0140-6736(22)01586-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01586-0</ArticleId><ArticleId IdType="pmc">PMC9539539</ArticleId><ArticleId IdType="pubmed">36216007</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Criteria for releasing COVID-19 patients from isolation. World Health Organization: Geneva. (2020). Available from: https://www.who.int/publications/i/item/criteria-for-releasing-covid-19-patients-fromisolation (accessed on July 17, 2020).</Citation></Reference><Reference><Citation>Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. (2020) 323:1775–6. doi: 10.1001/jama.2020.4683, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4683</ArticleId><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. (2020) 8:475–81. doi: 10.1016/S2213-2600(20)30079-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061–9. doi: 10.1001/jama.2020.1585, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497–506. doi: 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al. . Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. (2021) 590:140–5. doi: 10.1038/s41586-020-2918-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2918-0</ArticleId><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoye C, Finamore P, Bellelli G, Coin A, Del Signore S, Fumagalli S, et al. . Computed tomography findings and prognosis in older COVID-19 patients. BMC Geriatr. (2022) 22:166. doi: 10.1186/s12877-022-02837-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-022-02837-7</ArticleId><ArticleId IdType="pmc">PMC8885320</ArticleId><ArticleId IdType="pubmed">35227201</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PK, Singh L, Dubey R, Singh S, Mehrotra R. Socioeconomic determinants of chronic health diseases among older Indian adults: a nationally representative cross-sectional multilevel study. BMJ Open. (2019) 9:e028426. doi: 10.1136/bmjopen-2018-028426, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028426</ArticleId><ArticleId IdType="pmc">PMC6731792</ArticleId><ArticleId IdType="pubmed">31494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related Diseases: role of inflammation triggers and cytokines. Front Immunol. (2018) 9:586. doi: 10.3389/fimmu.2018.00586, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00586</ArticleId><ArticleId IdType="pmc">PMC5900450</ArticleId><ArticleId IdType="pubmed">29686666</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara LA, Wiegand RE, Burke RM, Sharma AJ, Sheppard M, Adjemian J, et al. . Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data. Lancet. (2022) 399:152–60. doi: 10.1016/S0140-6736(21)02226-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02226-1</ArticleId><ArticleId IdType="pmc">PMC8565933</ArticleId><ArticleId IdType="pubmed">34741818</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Khunti K. COVID-19 and diabetes. Annu Rev Med. (2022) 73:129–47. doi: 10.1146/annurev-med-042220-011857</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042220-011857</ArticleId><ArticleId IdType="pubmed">34379444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, et al. . Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. (2023) 23:1119–29. doi: 10.1016/S1473-3099(23)00299-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, et al. . Randomized trial of metformin, Ivermectin, and fluvoxamine for Covid-19. N Engl J Med. (2022) 387:599–610. doi: 10.1056/NEJMoa2201662, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2201662</ArticleId><ArticleId IdType="pmc">PMC9945922</ArticleId><ArticleId IdType="pubmed">36070710</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Lu Z, Zhang X, Wang Y, Wang J, Cai Y, et al. . Clinical characteristics and risk factors of fatal patients with COVID-19: a retrospective cohort study in Wuhan, China. BMC Infect Dis. (2021) 21:951. doi: 10.1186/s12879-021-06585-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06585-8</ArticleId><ArticleId IdType="pmc">PMC8439538</ArticleId><ArticleId IdType="pubmed">34521370</ArticleId></ArticleIdList></Reference><Reference><Citation>Goicoechea M, Sánchez Cámara LA, Macías N, Muñoz de Morales A, Rojas ÁG, Bascuñana A, et al. . COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. (2020) 98:27–34. doi: 10.1016/j.kint.2020.04.031, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7211728</ArticleId><ArticleId IdType="pubmed">32437770</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. . Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. (2020) 201:1372–9. doi: 10.1164/rccm.202003-0543OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0543OC</ArticleId><ArticleId IdType="pmc">PMC7258652</ArticleId><ArticleId IdType="pubmed">32242738</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. (2020) 20:269–70. doi: 10.1038/s41577-020-0308-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. (2020) 71:769–77. doi: 10.1093/cid/ciaa272, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa272</ArticleId><ArticleId IdType="pmc">PMC7184452</ArticleId><ArticleId IdType="pubmed">32176772</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğlu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. (2021) 372:n436. doi: 10.1136/bmj.n436</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n436</ArticleId><ArticleId IdType="pubmed">33692022</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Zhang M, Chen C, Zhang H, Wei Y, Tian J, et al. . Clinical characteristics of COVID-19 in patients with preexisting ILD: a retrospective study in a single center in Wuhan, China. J Med Virol. (2020) 92:2742–50. doi: 10.1002/jmv.26174</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26174</ArticleId><ArticleId IdType="pmc">PMC7322991</ArticleId><ArticleId IdType="pubmed">32533777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. (2020) 55:105954. doi: 10.1016/j.ijantimicag.2020.105954, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105954</ArticleId><ArticleId IdType="pmc">PMC7118634</ArticleId><ArticleId IdType="pubmed">32234467</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. (2020) 368:473–4. doi: 10.1126/science.abb8925</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. (2020) 52:731–3. doi: 10.1016/j.immuni.2020.04.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7175868</ArticleId><ArticleId IdType="pubmed">32325025</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivan MA, Rigatti B, da Cunha SV, Frison GC, Antoniazzi LQ, de Oliveira PHK, et al. . Pulmonary embolism in patients with COVID-19 and D-dimer diagnostic value: a retrospective study. Braz J Infect Dis. (2022) 26:102702. doi: 10.1016/j.bjid.2022.102702, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2022.102702</ArticleId><ArticleId IdType="pmc">PMC9436892</ArticleId><ArticleId IdType="pubmed">36096159</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Zhou Q, Jia Y, Xu J. Age- and sex-specific reference intervals for myocardial enzyme activity in healthy Chinese Han population aged 1∼&lt;18 years. Biomed Res Int. (2019) 2019:2018598. doi: 10.1155/2019/2018598, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2018598</ArticleId><ArticleId IdType="pmc">PMC6942733</ArticleId><ArticleId IdType="pubmed">31930113</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. . An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. (2000) 908:244–54. doi: 10.1111/j.1749-6632.2000.tb06651.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Zhong NS. Clinical characteristics of Covid-19 in China. Reply N Engl J Med. (2020) 382:1861–2. doi: 10.1056/NEJMc2005203, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2005203</ArticleId><ArticleId IdType="pubmed">32220206</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal RC, Ferdinand KC, Ycas J, Miller E. Relationship of ethnic origin, gender, and age to blood creatine kinase levels. Am J Med. (2009) 122:73–8. doi: 10.1016/j.amjmed.2008.08.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.08.033</ArticleId><ArticleId IdType="pubmed">19114174</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Cheng J, Wang M, Xing SH. Rhabdomyolysis with pericardial tamponade and myocardial hypertrophy in a child:a case report. J Chongqing Medical University. (2023) 48:362–5. doi: 10.13406/j.cnki.cyxb.003034</Citation><ArticleIdList><ArticleId IdType="doi">10.13406/j.cnki.cyxb.003034</ArticleId></ArticleIdList></Reference><Reference><Citation>Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, et al. . Leaf DE; STOP-COVID investigators. Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis. (2021) 77:190–203. doi: 10.1053/j.ajkd.2020.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7501875</ArticleId><ArticleId IdType="pubmed">32961244</ArticleId></ArticleIdList></Reference><Reference><Citation>Urazov S, Chernov A, Popov O, Klenkova N, Sushentseva N, Polkovnikova I, et al. . Secretory phospholipase A2 and Interleukin-6 levels as predictive markers of the severity and outcome of patients with COVID-19 infections. Int J Mol Sci. (2023) 24:5540. doi: 10.3390/ijms24065540, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065540</ArticleId><ArticleId IdType="pmc">PMC10059025</ArticleId><ArticleId IdType="pubmed">36982611</ArticleId></ArticleIdList></Reference><Reference><Citation>Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. (2020) 97:824–8. doi: 10.1016/j.kint.2020.03.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7133222</ArticleId><ArticleId IdType="pubmed">32204907</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillard S, Chavarot N, Francois H, Matignon M, Greze C, Kamar N, et al. . Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. (2021) 21:1295–303. doi: 10.1111/ajt.16424, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16424</ArticleId><ArticleId IdType="pmc">PMC7753418</ArticleId><ArticleId IdType="pubmed">33259686</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman M, Soler MJ, García-Carro C, Lightstone L, Turner-Stokes T, Griffith M, et al. . Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. Kidney Int. (2021) 99:227–37. doi: 10.1016/j.kint.2020.10.032, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.10.032</ArticleId><ArticleId IdType="pmc">PMC7833801</ArticleId><ArticleId IdType="pubmed">33181156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, Tu C, Xiong F, Sun X, Tian JB, Dong JW, et al. . Risk factors for the mortality of hemodialysis patients with COVID-19: a multicenter study from the overall hemodialysis population in Wuhan. Semin Dial. (2022) 35:71–80. doi: 10.1111/sdi.12995, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sdi.12995</ArticleId><ArticleId IdType="pmc">PMC8447194</ArticleId><ArticleId IdType="pubmed">34137080</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Ai H, Fu Y, Li Q, Cui R, Ma X, et al. . Development of an early warning model for predicting the death risk of coronavirus disease 2019 based on data immediately available on admission. Front Med (Lausanne). (2021) 8:699243. doi: 10.3389/fmed.2021.699243, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.699243</ArticleId><ArticleId IdType="pmc">PMC8416661</ArticleId><ArticleId IdType="pubmed">34490294</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. (2021) 17:46–64. doi: 10.1038/s41581-020-00357-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00357-4</ArticleId><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Wang H, Lv J, Pei H, Bai Z. Predictors of mortality in hospitalized COVID-19 patients complicated with hypotension and hypoxemia: a retrospective cohort study. Front Med (Lausanne). (2021) 8:753035. doi: 10.3389/fmed.2021.753035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.753035</ArticleId><ArticleId IdType="pmc">PMC8581201</ArticleId><ArticleId IdType="pubmed">34778315</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, et al. . Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet. Respir Med. (2020) 8:1201–8. doi: 10.1016/S2213-2600(20)30370-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30370-2</ArticleId><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>